دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 4th نویسندگان: S. Swerdlow, et al. سری: IARC WHO Classification of Tumours ISBN (شابک) : 928324494X, 9789283244943 ناشر: WHO سال نشر: 2017 تعداد صفحات: 588 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 76 مگابایت
کلمات کلیدی مربوط به کتاب طبقه بندی تومورهای بافت خون ساز و لنفوئیدی WHO: پزشکی، دایره المعارف ها و راهنمای موضوع، مرجع، بهداشت عمومی، اپیدمیولوژی، مدیریت و اقتصاد پزشکی، انکولوژی، داخلی، پزشکی، آسیب شناسی، شیمی بالینی، پزشکی قانونی، پزشکی آزمایشگاهی، بیماری ها، داخلی و اصطلاحات، پزشکی، پزشکی راهنمای دارویی، ابزار و لوازم، اطلس پزشکی، پزشکی
در صورت تبدیل فایل کتاب WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب طبقه بندی تومورهای بافت خون ساز و لنفوئیدی WHO نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
طبقه بندی تومورهای بافت های خون ساز و لنفوئیدی WHO
ویرایش چهارم تجدید نظر شده سری WHO در مورد نوع بافت شناسی و
ژنتیکی تومورهای انسانی است. این مرجع معتبر و مختصر یک استاندارد
بین المللی برای انکولوژیست ها و پاتولوژیست ها ارائه می دهد و به
عنوان یک راهنمای ضروری برای استفاده در طراحی مطالعات نظارت بر
پاسخ به درمان و نتیجه بالینی عمل می کند.
معیارهای تشخیصی، ویژگیهای پاتولوژیک و تغییرات ژنتیکی مرتبط به
روشی کاملاً مبتنی بر بیماری توصیف میشوند. بخشهای مربوط به همه
نئوپلاسمهای شناختهشده و انواع آنها شامل کدهای جدید ICD-O،
اپیدمیولوژی، ویژگیهای بالینی، ماکروسکوپی، پیشآگهی و عوامل
پیشبینیکننده است.
این طبقهبندی که توسط 132 نویسنده از 23 کشور تهیه شده است، شامل
حدود 1300 تصویر و جدول رنگی و بیش از 4500 مرجع.
WHO Classification of Tumours of Haematopoietic and Lymphoid
Tissues is a Revised Fourth Edition of the WHO series on
histological and genetic typing of human tumours. This
authoritative, concise reference provides an international
standard for oncologists and pathologists and will serve as an
indispensable guide for use in the design of studies monitoring
response to therapy and clinical outcome.
Diagnostic criteria, pathological features, and associated
genetic alterations are described in a strictly
disease-oriented manner. Sections on all recognized neoplasms
and their variants further include new ICD-O codes,
epidemiology, clinical features, macroscopy, prognosis, and
predictive factors.
This classification, prepared by 132 authors from 23 countries,
contains about 1300 color images and tables and more than 4500
references.
WHO classification of tumours of haematopoietic and lymphoid tissues 10 Introduction to the WHO classification of tumours of haematopoietic and lymphoid tissues 13 1 Introduction and overview of the classification of the myeloid neoplasms 15 2 Myeloproliferative neoplasms 29 Chronic myeloid leukaemia, BCR-ABL1-positive 30 Chronic neutrophilic leukaemia 37 Polycythaemia vera 39 Primary myelofibrosis 44 Prefibrotic/early primary myelofibrosis 46 Overt primary myelofibrosis 48 Essential thrombocythaemia 50 Chronic eosinophilic leukaemia, not otherwise specified 54 Myeloproliferative neoplasm, unclassifiable 57 3 Mastocytosis 61 Cutaneous mastocytosis 65 Systemic mastocytosis 66 Mast cell sarcoma 69 4 Myeloid/lymphoid neoplasms with eosinophilia and gene rearrangement 71 Myeloid/lymphoid neoplasms with PDGFRA rearrangement 73 Myeloid/lymphoid neoplasms with PDGFRB rearrangement 75 Myeloid/lymphoid neoplasms with FGFR1 rearrangement 77 Myeloid/lymphoid neoplasms with PCM1-JAK2 78 5 Myelodysplastic/myeloproliferative neoplasms 81 Chronic myelomonocytic leukaemia 82 Atypical chronic myeloid leukaemia, BCR-ABL1-negative 87 Juvenile myelomonocytic leukaemia 89 Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis 93 Myelodysplastic/myeloproliferative neoplasm, unclassifiable 95 6 Myelodysplastic syndromes 97 Overview 98 Myelodysplastic syndrome with single lineage dysplasia 106 Myelodysplastic syndrome with ring sideroblasts 109 Myelodysplastic syndrome with multilineage dysplasia 111 Myelodysplastic syndrome with excess blasts 113 Myelodysplastic syndrome with excess blasts and erythroid predominance 114 Myelodysplastic syndrome with excess blasts and fibrosis 114 Myelodysplastic syndrome with isolated del(5q) 115 Myelodysplastic syndrome, unclassifiable 116 Childhood myelodysplastic syndrome 116 Refractory cytopenia of childhood 117 7 Myeloid neoplasms with germline predisposition 121 Myeloid neoplasms with germline predisposition without a pre-existing disorder or organ dysfunction 124 Acute myeloid leukaemia with germline CEBPA mutation 124 Myeloid neoplasms with germline DDX41 mutation 125 Myeloid neoplasms with germline predisposition and pre-existing platelet disorders 125 Myeloid neoplasms with germline RUNX1 mutation 125 Myeloid neoplasms with germline ANKRD26 mutation 125 Myeloid neoplasms with germline ETV6 mutation 126 Myeloid neoplasms with germline predisposition associated with other organ dysfunction 126 Myeloid neoplasms with germline GATA2 mutation 126 Myeloid neoplasms with germline predisposition associated with inherited bone failure syndromes and telomere biology disorders 128 8 Acute myeloid leukaemia and related precursor neoplasms 129 Acute myeloid leukaemia with recurrent genetic abnormalities 130 Introduction 130 Acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 130 Acute myeloid leukaemia with inv(16)(p13.1 q22) or t(16; 16)(p 13.1 ;q22); CBFB-MYH11 132 Acute promyelocytic leukaemia with PML-RARA 134 Acute myeloid leukaemia with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 136 Acute myeloid leukaemia with t(6;9)(p23;q34.1); DEK-NUP214 137 Acute myeloid leukaemia with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM 138 Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 139 Acute myeloid leukaemia with BCR-ABL1 140 Acute myeloid leukaemia with gene mutations 141 Acute myeloid leukaemia with mutated NPM1 141 Acute myeloid leukaemia with biallelic mutation of CEBPA 142 Acute myeloid leukaemia with mutated RUNX1 144 Acute myeloid leukaemia with myelodysplasia-related changes 150 Therapy-related myeloid neoplasms 153 Acute myeloid leukaemia, not otherwise specified 156 Acute myeloid leukaemia with minimal differentiation 156 Acute myeloid leukaemia without maturation 157 Acute myeloid leukaemia with maturation 158 Acute myelomonocytic leukaemia 159 Acute monoblastic and monocytic leukaemia 160 Pure erythroid leukaemia 161 Acute megakaryoblastic leukaemia 162 Acute basophilic leukaemia 164 Acute panmyelosis with myelofibrosis 165 Myeloid sarcoma 167 Myeloid proliferations associated with Down syndrome Transient abnormal myelopoiesis associated with Down syndrome Myeloid leukaemia associated with Down syndrome 169 169 170 9 Blastic plasmacytoid dendritic cell neoplasm 173 10 Acute leukaemias of ambiguous lineage 179 Acute undifferentiated leukaemia 182 Mixed-phenotype acute leukaemia with t(9;22)(q34.1 ;q11.2); BCR-ABL1 182 Mixed-phenotype acute leukaemia with t(v;11q23.3); KMT2A-re arranged 183 Mixed-phenotype acute leukaemia, B/myeloid, not otherwise specified 184 Mixed-phenotype acute leukaemia, T/myeloid, not otherwise specified 185 Mixed-phenotype acute leukaemia, not otherwise specified, rare types 186 Acute leukaemias of ambiguous lineage, not otherwise specified 187 11 Introduction and overview of the classification of the lymphoid neoplasms 189 12 Precursor lymphoid neoplasms 199 B-lymphoblastic leukaemia/lymphoma, not otherwise specified 200 B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities 203 B-lymphoblastic leukaemia/lymphoma with t(9;22)(q34.1 ;q11.2); BCR-ABL 1 203 B-lymphoblastic leukaemia/lymphoma with t(v;11q23.3); K7W724-rearranged 203 B-lymphoblastic leukaemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 204 B-lymphoblastic leukaemia/lymphoma with hyperdiploidy 205 B-lymphoblastic leukaemia/lymphoma with hypodiploidy 206 B-lymphoblastic leukaemia/lymphoma with t(5; 14)(q31.1 ;q32.1); IGH//L3 206 B-lymphoblastic leukaemia/lymphoma with t(1 ;19)(q23;p13.3); TCF3-PBX1 207 B-lymphoblastic leukaemia/lymphoma, BCR-ABL1-like 208 B-lymphoblastic leukaemia/lymphoma with iAMP21 208 T-lymphoblastic leukaemia/lymphoma Early T-cell precursor lymphoblastic leukaemia 209 212 NK-lymphoblastic leukaemia/lymphoma 213 13 Mature B-cell neoplasms 215 Chronic lymphocytic leukaemia/ small lymphocytic lymphoma 216 Monoclonal B-cell lymphocytosis 220 B-cell prolymphocytic leukaemia 222 Splenic marginal zone lymphoma 223 Hairy cell leukaemia 226 Splenic B-cell lymphoma/leukaemia, unclassifiable 229 Splenic diffuse red pulp small B-cell lymphoma 229 Hairy cell leukaemia variant 230 Lymphoplasmacytic lymphoma 232 IgM Monoclonal gammopathy of undetermined significance 236 Heavy chain diseases 237 Mu heavy chain disease 237 Gamma heavy chain disease 238 Alpha heavy chain disease 240 Plasma cell neoplasms 241 Non-IgM monoclonal gammopathy of undetermined significance 241 Plasma cell myeloma 243 Plasma cell myeloma variants 249 Smouldering (asymptomatic) plasma cell myeloma 249 Non-secretory myeloma 250 Plasma cell leukaemia 250 Plasmacytoma 250 Solitary plasmacytoma of bone 250 Extraosseous plasmacytoma 251 Monoclonal immunoglobulin deposition diseases 254 Primary amyloidosis 254 Light chain and heavy chain deposition diseases 255 Plasma cell neoplasms with associated paraneoplastic syndrome 256 POEMS syndrome 256 TEMPI syndrome 257 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) 259 Nodal marginal zone lymphoma 263 Paediatric nodal marginal zone lymphoma 264 Follicular lymphoma 266 Testicular follicular lymphoma 268 In situ follicular neoplasia 274 Duodenal-type follicular lymphoma 276 Paediatric-type follicular lymphoma 278 Large B-cell lymphoma with IRF4 rearrangement 280 Primary cutaneous follicle centre lymphoma 282 Mantle cell lymphoma 285 Leukaemic non-nodal mantle cell lymphoma 290 In situ mantle cell neoplasia 290 Diffuse large B-cell lymphoma (DLBCL), NOS 291 T-cell/histiocyte-rich large B-cell lymphoma 298 Primary diffuse large B-cell lymphoma of the CNS 300 Primary cutaneous diffuse large B-cell lymphoma, leg type 303 EBV-positive diffuse large B-cell lymphoma, NOS 304 EBV-positive mucocutaneous ulcer 307 Diffuse large B-cell lymphoma associated with chronic inflammation 309 Fibrin-associated diffuse large B-cell lymphoma 311 Lymphomatoid granulomatosis 312 Primary mediastinal (thymic) large B-cell lymphoma 314 Intravascular large B-cell lymphoma 317 ALK-positive large B-cell lymphoma 319 Plasmablastic lymphoma 321 Primary effusion lymphoma 323 HHV8-associated lymphoproliferative disorders 325 Multicentric Castleman disease 325 HHV8-positive diffuse large B-cell lymphoma, NOS 327 HHV8-positive germinotropic lymphoproliferative disorder 328 Burkitt lymphoma 330 Burkitt-like lymphoma with 11 q aberration 334 High-grade B-cell lymphoma 335 High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements 335 High-grade B-cell lymphoma, NOS 340 B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma 342 14 Mature T- and NK-cell neoplasms 345 T-cell prolymphocytic leukaemia 346 T-cell large granular lymphocytic leukaemia 348 Chronic lymphoproliferative disorder of NK cells 351 Aggressive NK-cell leukaemia 353 EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood 355 Systemic EBV+ T-cell lymphoma of childhood Chronic active EBV infection of T- and NK-cell type, systemic form Hydroa vacciniforme-like lymphoproliferative disorder Severe mosquito bite allergy 355 358 360 362 Adult T-cell leukaemia/lymphoma 363 Extranodal NK/T-cell lymphoma, nasal type 368 Intestinal T-cell lymphoma 372 Enteropathy-associated T-cell lymphoma 372 Monomorphic epitheliotropic intestinal T-cell lymphoma 377 Intestinal T-cell lymphoma, NOS 378 Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract 379 Hepatosplenic T-cell lymphoma 381 Subcutaneous panniculitis-like T-cell lymphoma 383 Mycosis fungoides 385 Sezary syndrome 390 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders 392 Lymphomatoid papulosis 392 Primary cutaneous anaplastic large cell lymphoma 395 Primary cutaneous peripheral T-cell lymphomas, rare subtypes 397 Introduction 397 Primary cutaneous gamma delta T-cell lymphoma 397 Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma 399 Primary cutaneous acral CD8-positive T-cell lymphoma Primary cutaneous CD4+ small/medium T-cell 400 lymphoproliferative disorder 401 Peripheral T-cell lymphoma, NOS 403 Angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T follicular helper (TFH) cell origin 407 Angioimmunoblastic T-cell lymphoma 408 Follicular T-cell lymphoma Nodal peripheral T-cell lymphoma with 411 TFH phenotype 412 Anaplastic large cell lymphoma, ALK-positive 413 Anaplastic large cell lymphoma, ALK-negative 418 Breast implant-associated anaplastic large cell lymphoma 421 15 Hodgkin lymphomas 423 Introduction 424 Nodular lymphocyte predominant Hodgkin lymphoma 431 Classic Hodgkin lymphoma 435 Nodular sclerosis classic Hodgkin lymphoma 435 Lymphocyte-rich classic Hodgkin lymphoma 438 Mixed-cellularity classic Hodgkin lymphoma 440 Lymphocyte depleted classic Hodgkin lymphoma 441 16 Immunodeficiency-associated lymphoproliferative disorders 443 Lymphoproliferative diseases associated with primary immune disorders 444 Lymphomas associated with HIV infection 449 Post-transplant lymphoproliferative disorders (PTLD) 453 Non-destructive PTLD 456 Polymorphic PTLD 457 Monomorphic PTLD (B- and T/NK-cell types) 459 Monomorphic B-cell PTLD 459 Monomorphic T/NK-cell PTLD 461 Classic Hodgkin lymphoma PTLD 462 Other iatrogenic immunodeficiency-associated lymphoproliferative disorders 462 17 Histiocytic and dendritic cell neoplasms 465 Introduction 466 Histiocytic sarcoma 468 Tumours derived from Langerhans cells 470 Langerhans cell histiocytosis 470 Langerhans cell sarcoma 473 Indeterminate dendritic cell tumour 474 Interdigitating dendritic cell sarcoma 475 Follicular dendritic cell sarcoma 476 Inflammatory pseudotumour-like follicular/fibroblastic dendritic cell sarcoma 478 Fibroblastic reticular cell tumour 479 Disseminated juvenile xanthogranuloma 480 Erdheim-Chester disease 481 Contributors 484 Declaration of interests 493 Clinical Advisory Committees 494 IARC/WHO Commitee for ICD-O 496 Sources of figures and tables 497 References 504 Subject index 577 List of abbreviations 586